长江商报消息 ●长江商报记者 沈右荣 并不差钱的丸美生物（603983.SH）欲赴港上市，募资补血。 12月12日晚，丸美生物发布公告，公司向港交所递交H股发行上市的申请并刊发申请资料。 此次IPO恐难言顺利。此前，丸美生物因为财务核算、募集资金使用等问题被广东证监局采取行政监管措施。11 月29日，公司才完成整改。 此外，从11月12日宣布筹划赴港上市到12月12日递交上市申请，丸美股份仅用时一个月，似乎有些匆忙。 2019年7月，丸美生物通过IPO登陆A股市场，上市以来，公司盈利能力并不稳定，其中2020年至2022年，公司归 母净利润三连降，2023年、2024年连续回升，仍然不及2019年水平。2025年，公司归母净利润失速，扣非净利润 则不增反降，且连续两个季度下滑。 丸美生物资金充足。截至2025年9月底，公司货币资金15.92亿元，远超有息负债5.73亿元。 基于此，丸美生物积极分红。上市以来，公司累计派发现金红利10.83亿元，整体分红率48.22%。长江商报记者计 算，这10.83亿元现金分红，丸美生物实际控制人孙怀庆夫妇拿走了8.75亿元。 刚完成整改即匆匆赴港IPO 在港股市场IPO监管 ...

Core Viewpoint - The Supreme People's Court ruled in favor of Huaying Technology, ordering Huaying Bermuda to pay 3.029 billion yuan in performance compensation, which is expected to significantly improve the company's financial situation despite uncertainties regarding the collection of the amount [1][2][3]. Group 1: Legal Proceedings - The lawsuit lasted seven years, originating from a performance commitment made by Huaying Bermuda after Huaying Technology's major asset restructuring in 2010 [1][4]. - Huaying Technology initiated the lawsuit in early 2019, seeking 1.914 billion yuan initially, which was later increased to 3.029 billion yuan after adding two more defendants [3][4][6]. - The court upheld the first-instance ruling, confirming that Huaying Bermuda must pay the compensation, while the other two defendants bear joint liability [3][4]. Group 2: Financial Impact - If the 3.029 billion yuan compensation is received, it will greatly enhance Huaying Technology's operational performance, which has been under pressure due to ongoing losses in the display panel industry [2][13]. - For the first three quarters of 2025, Huaying Technology reported a revenue of 1.039 billion yuan, a year-on-year decrease of 21.03%, and a net loss of 722 million yuan, although this represented a reduction in losses compared to the previous year [11][12]. - Since 2016, the company has accumulated a non-recurring net profit loss of approximately 150.58 billion yuan, indicating a challenging financial history [12]. Group 3: Company Background - Huaying Technology, originally Min Dong Electric, underwent a significant asset restructuring in 2010, changing its main business to the research, production, and sales of display panels and modules [4][10]. - The company has faced declining revenues since 2016, with revenue dropping from over 40 billion yuan to 1.739 billion yuan by 2024 [10][12]. - In 2020, Huaying Technology changed ownership, with the Electronic Information Group becoming the controlling shareholder [12].

长江商报消息 三元材料龙头容百科技（688005.SH）借并购抄底磷酸铁锂行业低效资产。 日前，容百科技披露对外投资计划，拟以股权收购及增资的方式，合计作价4.82亿元取得贵州新仁新能 源科技有限公司（以下简称"贵州新仁"）93.2034%股权。交易完成后，贵州新仁成为容百科技控股子公 司，纳入上市公司合并报表范围。 长江商报记者注意到，贵州新仁目前处于亏损状态。本次交易中，贵州新仁经审计净资产为5.73亿元， 整体估值为3.99亿元，折价约30.4%。这意味着，容百科技将以低价并购行业过剩产能的方式，快速获 得贵州新仁年产6万吨磷酸铁锂产线，完善产业布局。 在当前自身业绩承压，以及贵州新仁持续亏损的背景下，容百科技面临严峻的资产整合与盈利挑战。 数据显示，受销量下降、产能闲置导致成本上升，以及在磷酸铁锂等新产业持续投入等因素影响，2025 年前三季度，容百科技实现营业收入89.86亿元，同比下降20.64%；归属于上市公司股东的净利润（以 下简称"归母净利润"）亏损2.04亿元，同比由盈转亏。其中，三季度，容百科技归母净利润亏损1.35亿 元，公司单季度首次亏损过亿元。 拟4.82亿控股贵州新仁 根据交易方 ...

皮匠嘴股票 "今天A股三大指数震荡调整，沪指冲高回落，创业板指低开低走。截至收盘，沪指报3867.92点，跌 0.55%，成交7646亿元；深证成指报13112.09点，跌1.10%，成交10088亿元；创业板指报3137.80点，跌 1.77%，成交4721亿元。沪深两市全天成交额17734亿元。行业板块涨跌互现，保险、商业百货、食品 饮料、化纤行业、贵金属板块涨幅居前，船舶制造、能源金属、半导体、生物制品、消费电子板块跌幅 居前。整体是一个倒V型走势。"牛皮匠说。 "受商务部、中国人民银行、金融监管总局联合发布《关于加强商务和金融协同更大力度提振消费的通 知》的利好刺激，消费板块逆市掀涨停潮。而近两周市场最强的航天板块开盘回调，航天发展 （000547）和航天动力（600343）一度杀到跌停附近，随后航天机电（600151）上板稳住局势，板块开 始回流。航天板块出现分歧滞涨高位，而上周较强的芯片、通信、科创板却出现明显的亏钱效应。"犟 皮匠说。 "今天涨跌家数大致是各一半，还有60多家涨停，指数没有行情，但板块和个股却有行情。上周五买的 争光股份（301092）逆市冲高，我趁机获利了结，这只股票算是争了个 ...

Core Viewpoint - The global laser industry has seen a significant increase in merger and acquisition activities since the second half of 2025, with companies like Jinchengzi, Guangku Technology, and Guangyunda accelerating their globalization and strengthening industry chain integration and technological collaboration [1] Group 1: Acquisition Details - Jinchengzi announced plans to acquire 55% of Samit through a combination of share issuance and cash payment, raising matching funds [1][3] - As of June 30, 2025, Samit's book value of equity attributable to the parent company was 41.9683 million yuan, with an assessed value of 342 million yuan, resulting in an appraisal increase of 300 million yuan and an increase rate of 715.77% [3][4] - The final transaction price for the 55% stake in Samit was agreed upon at 188 million yuan [4] Group 2: Performance Commitments - The counterparties have committed to achieving net profits of no less than 26.8 million yuan, 30.5 million yuan, and 34.2 million yuan for the years 2025, 2026, and 2027, respectively, totaling 91.5 million yuan over three years [4] Group 3: Company Background and Product Offerings - Jinchengzi is a leading company in the field of laser processing control systems, focusing on automation and intelligence in advanced laser manufacturing [2] - Samit specializes in the research, production, and sales of precision optoelectronic control products, with key products including fast mirrors and high-precision mirrors [3][5] Group 4: Financial Performance - For the first three quarters of 2025, Jinchengzi reported revenues of 185 million yuan, a year-on-year increase of 15.80%, and a net profit of 36.5129 million yuan, up 32.86% year-on-year [6] - The company’s net profit excluding non-recurring gains and losses grew by 55.97% [6] Group 5: Asset Transactions - Jinchengzi is also divesting assets, having agreed to sell a 15% stake in Suzhou Kamenhas Laser Technology for 75 million yuan, which was a profit of 35 million yuan from a previous investment [7][8] - Kamenhas achieved revenues of 240 million yuan and 106 million yuan in 2024 and the first half of 2025, respectively, with net profits of 17.4005 million yuan and 9.5404 million yuan [9]

Economic Overview - In November, the national economy continued to operate smoothly, with a focus on high-quality development and stable production supply [1][3] - The total grain output for the year reached 14.298 trillion jin, an increase of 167.5 billion jin or 1.2% year-on-year [1] Industrial Performance - The industrial production showed stable growth, with the industrial added value of large-scale enterprises increasing by 4.8% year-on-year in November and 6.0% from January to November [1] - The profit of large-scale industrial enterprises totaled 59,503 billion yuan from January to October, reflecting a year-on-year increase of 1.9% [1] Service Sector - The service sector maintained steady growth, with the service production index rising by 4.2% year-on-year in November and 5.6% from January to November [1] - The revenue of large-scale service enterprises increased by 7.6% year-on-year from January to October [1] Consumer Market - The total retail sales of consumer goods reached 43,898 billion yuan in November, showing a year-on-year growth of 1.3% [2] - Rural retail sales grew by 2.8%, while urban retail sales increased by 1.0% [2] Investment Trends - Fixed asset investment (excluding rural households) decreased by 2.6% year-on-year from January to November, while manufacturing investment grew by 1.9% [2] - Real estate development investment saw a significant decline of 15.9% [2] Trade Performance - The total import and export value in November was 38,987 billion yuan, with a year-on-year growth of 4.1% [2] - Exports increased by 5.7% to 23,456 billion yuan, while imports rose by 1.7% to 15,531 billion yuan [2] Employment and Prices - The urban survey unemployment rate remained stable at 5.1% in November [3] - The Consumer Price Index (CPI) rose by 0.7% year-on-year, with an increase of 0.5 percentage points compared to the previous month [3]

在健康饮食浪潮的推动下，魔芋这一曾默默无闻的食材，正经历着从火锅配菜到零食"流量明星"的转身。 12月10日，"健康零食新主张 超级食材魔芋爽"发布会在云南西双版纳召开。本次活动汇聚了营养专家、行业协会代表、产业链企业代表卫龙及媒体代表 等多方力量，共同解码魔芋产业的转型路径与未来机遇。 作为关键推动者，卫龙凭借敏锐的市场洞察力与持续创新能力，不仅引领魔芋零食行业从"拓荒"走向"引领"，更推动魔芋产业从"小产业"迈向"大集群"， 为国民健康食品发展注入新动能。 01 从"拓荒者"到"引领者" 我国现有魔芋加工企业200多家，其中国家级农业产业化龙头企业10余家、规模以上企业150余家，主要集中在四川、湖北、陕西、云南等原料主产区，形 成"原料企业（供应精粉/干片）—制品企业（生产终端食品）—产业集群（区域协同）"企业格局。 在种植端，我国已成为全球魔芋第一大国。中国园艺协会魔芋分会发布的数据显示，中国魔芋产量占全球的65%，魔芋种植面积约为240万亩。 02 从"试验田"到"增长极" 从火锅配菜，到走入零食赛道，魔芋以其独有的"健康密码"，成为"流量明星"。卫龙是这一蜕变的关键推动者，也成功将魔芋从"试验田" ...

深陷医药行贿丑闻，信邦制药（002390.SZ）被检察机关移送起诉。 12月10日晚，信邦制药发布公告，公司涉嫌单位行贿一案，检察机关已经收到监察委员会移送起诉的材料。 点击蓝字关注我们 长江商报记者 沈右荣 2025年2月，贵阳开阳县人民法院立案受理贵州科开医药有限公司（以下简称"科开医药"）涉嫌单位行贿罪、安怀略涉嫌行贿罪一案。科开医药系信邦制 药控股子公司，安怀略系信邦制药前董事长，现任董事长安吉之父。 此案的刑事判决，将对信邦制药产生多大影响，暂且无从知晓。二级市场上，12月11日、12日，信邦制药股价连续跌停。 信邦制药是一家覆盖医疗服务、医药流通和医药制造的医疗健康全产业链集团，2010年登陆A股市场。 近年来，信邦制药经营业绩萎靡。2024年及2025年前三季度，公司业绩持续双降。 信邦制药研发投入不多。2025年前九个月，公司的研发投入为429.26万元。与之对应的是，公司销售费用1.96亿元，大幅高于研发投入。 公司及子公司均涉单位行贿 信邦制药及其控股子公司均涉嫌单位行贿。 根据公告，近日，信邦制药收到了检察机关《审查起诉阶段委托辩护人/申请法律援助告知书》《犯罪嫌疑人诉讼权利义务告知书》 ...

Core Viewpoint - Chongqing Yulong Optoelectronics Technology Co., Ltd. (Yulong Technology) is transitioning from the Shanghai Stock Exchange main board to the ChiNext board for its IPO, aiming to raise 1 billion yuan, which is 500 million yuan less than its previous attempt in 2023 [1][3] Group 1: IPO Details - Yulong Technology's IPO application has been accepted by the Shenzhen Stock Exchange, with a fundraising target of 1 billion yuan, primarily for projects in Hefei and Chongqing, and 300 million yuan for working capital [1][3] - The company previously attempted to list on the Shanghai main board in March 2023, seeking to raise 1.5 billion yuan but withdrew its application after three months [3] Group 2: Ownership Structure - Wang Yalong and Li Hongyan control 74.16% of Yulong Technology, with Wang Yalong also being the actual controller of the listed company Lite Optoelectronics [1][3] - If successful, this IPO would allow Wang Yalong to control two listed companies in the A-share market [1][3] Group 3: Customer Concentration - Yulong Technology has a high dependency on major customer BOE Technology Group Co., Ltd., with revenue from BOE accounting for 53.58% of its main business income in the first half of 2025 [1][4] - The top five customers contribute significantly to Yulong Technology's revenue, with their combined income accounting for 94.02% [1][4] Group 4: Financial Performance - The company's gross profit margin has decreased from 38.36% in 2019 to 22.56% in the first half of 2025, indicating a significant reduction in profitability [1][7] - Yulong Technology's revenue and net profit figures show fluctuations, with a notable decline in net profit by 42.3% in 2022 despite a slight increase in revenue [6][7] - Accounts receivable have risen to 443 million yuan, constituting 48.79% of the company's current assets, indicating potential liquidity pressures [2][8]

原标题：东莞银行业绩承压A股候场17年无果 两年被罚1332万董监高涨薪225万 长江商报消息 ●长江商报记者 徐佳 冲刺A股17年未果，东莞银行股份有限公司（以下简称"东莞银行"）正面临合规治理与业绩下滑的双重 挑战。 近日，中国人民银行广东省分行对东莞银行作出行政处罚决定。因违反金融统计、支付结算等相关规 定，东莞银行被警告并罚没387.04万元。 据长江商报记者不完全统计，2024年以来，东莞银行总行及分支机构合计被罚1332万元，其中百万级罚 单就有四张。 东莞银行的经营层面同样压力显现。2025年前三季度，东莞银行实现营业收入69.17亿元，同比减少约 9.4%；归属于母公司股东的净利润（以下简称"归母净利润"）25.46亿元，同比减少20.7%。继2024年之 后，东莞银行再次出现营收、归母净利润双降。 截至2025年9月末，东莞银行核心一级资本充足率已由2024年末的9.31%降至9.13%，资本补充需求迫 切。 值得关注的是，业绩下行期间，2024年，东莞银行的董监高薪酬总额2515万元，同比增加225万元，增 长9.8%。 在IPO进程屡因财务资料过期而中止、内控漏洞频现的背景下，如何完善治 ...